Notably, MET amplification-driven cancer cells (EBC-1, NCI-H1993, MKN-45 and SNU-5) were most sensitive to Simm530 treatment, with IC50 values of 0.7, 0.8, 0.9 and 0.7 nM, respectively (Figure 3A, Table S1). Here, MET is linked to cancer.